Lissun
PrivateLast Round
Series A
Aug 18, 2026
Est. Valuation
$16.8M
Total Funding Raised
$8.39M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lissun operates in Healthcare & Life Sciences and is based in India. Its latest recorded funding round was a Series A round in August 2026.
Lissun is a health-tech company that provides an omnichannel mental and emotional wellness platform offering therapy, counseling, and child development services.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lissun Comparables
Compare Lissun with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amaha | 78% | |
| YourDOST | 76% | |
| Wysa | 76% |
For institutional investors. Book with your work email.
Lissun Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 18, 2026 | ||||
| Convertible Debt | Jun 17, 2026 | ||||
| VC Round | Sep 30, 2024 | ||||
| Seed | Sep 4, 2023 | ||||
| Pre Seed | Sep 28, 2022 |
For institutional investors. Book with your work email.
Lissun Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RPSG Ventures Limited | Series A, VC Round |
| Atrium Angels | VC Round |
| Inflection Point Ventures | Seed |
| New Age India Fund | Series A |
| Rainmatter Capital Fund | VC Round, Series A, Convertible Debt, Seed |
| Colossa Ventures | Series A |
| SucSEED Venture Partners | VC Round, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2026
$6M round led by Colossa Ventures.
- Aug 3, 2026
Open roles increased to 145, 2.3x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 18, 2026
On Aug 18th '26, Lissun plans to develop AI-enabled solutions using its proprietary technology and data in Haryana while strengthening clinical processes.
- receives_financingAug 18, 2026
In Jul '26, Lissun is in talks to receive around $5.02M in Series A financing led by Colossa Ventures.
- identified_as_competitor_ofAug 18, 2026
Lissun competes with Continua Kids in India’s child-focused health-tech market.
For institutional investors. Book with your work email.
Lissun Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lissun's valuation, stock price, and market status.
Is Lissun a public or private company?
Lissun is a private company.
What is the current stock price of Lissun?
Lissun is a private company, so its shares have no public market price. Caplight tracks Lissun's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lissun worth (valuation)?
Lissun's valuation is estimated at $16.8M based on funding round data.
Can I buy Lissun stock?
Lissun shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lissun's last funding round?
Lissun's most recent funding round was Series A on August 18, 2026.
Who are the main investors in Lissun?
Key investors in Lissun include RPSG Ventures Limited, Inflection Point Ventures, Rainmatter Capital Fund, Colossa Ventures, IvyCap Ventures.
Will Lissun IPO soon?
No public IPO plans have been announced for Lissun.
How can I track Lissun secondary market activity?
Caplight tracks bids, offers, and trades in Lissun's shares on secondary markets.